awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35167535-26B844CC-B8C3-4763-A055-E2C1689EA582
Q35167535-26B844CC-B8C3-4763-A055-E2C1689EA582
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35167535-26B844CC-B8C3-4763-A055-E2C1689EA582
Cost-effectiveness analyses of targeted oral anti-cancer drugs: a systematic review.
P2860
Q35167535-26B844CC-B8C3-4763-A055-E2C1689EA582
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35167535-26B844CC-B8C3-4763-A055-E2C1689EA582
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ace7dc8b26cc1d3376ed2c6aec29ecf1301e3412
P2860
Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: a real-world cost-effectiveness analysis.